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LETTER TO THE EDITOR
To the Editors;
With great initial interest we read the report of brothers
with a neuroacanthocytosis syndrome1 but were later disap-
pointed by the unmentioned fact that the details of the cases
are identical to those of a previous publication by the sen-
ior author2. Despite the time interval of 22 years since that
original paper, the only significant additions in this dupli-
cate publication are the color video stills and the figure of
the brain MRI. Figure 1, of a peripheral blood smear with
acanthocytes, was already made available to the public in
an online medical resource3 (www.emedicine.com) and the
connection with the present cases remains unclear. There is
a hint that post mortem examination may have been per-
formed as a further new fact. This, however, is mentioned
only very briefly and could also be read as a reference to
general knowledge about the neuropathological findings in
neuroacanthocytosis syndromes. The argument of keeping
an open mind for differential diagnosis that may have driven
Lakhan and Gross to discuss these cases again is somewhat
trivial.
Although the erythrocyte Kell antigen results mentioned
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NEUROACANTHOCYTOSIS
by the authors suggest that their patients did not have the
McLeod neuroacanthocytosis syndrome, for confirmation
of the suspected diagnosis of chorea-acanthocytosis (MIM
200150) it would have been of great interest to perform ge-
netic analysis4 or the Western blot test for chorein5, which
is now available through the support of the Advocacy for
Neuroacanthocytosis patients (www.naadvocacy.org).
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Editor´s note: Having received this letter on December 18th, 2007, Clinics immediately wrote to Dr. SE Lakhan, about this
apparent duplication, and received (on December 19th) an e-mail in which Dr. Lakhan stated that:
“…our report submitted to your journal is a clinical practice piece with brief literature review of neuroacanthocytosis. It weaves
the special case of the 46 year old Hispanic with this disease, however, not to introduce a novel presentation of a disease per se, but
to demonstrate the workup and differential of such a presentation.”
Having thus established positive communication, Clinics forwarded the full text of this letter to Dr. Lakham on December 21st,
with an offer to add as Discussion any comments he might wish to add to the matter. To include such comments in this issue we
established January 7th, 2008 as a deadline to receive his comments.
Having not heard from Dr. Lakham, we understand that the content of this letter stands unopposed and that CLINICS owes an
apology to its readers for unintentionally publishing what must be described as an outright duplication of previously published ma-
terial. The 22 year interval between original and duplicate publications in a way excuses our reviewers for overlooking the previ-
ously published report.
